key: cord-0715719-l211d603
authors: Sauter, Jennifer L.; Baine, Marina K; Butnor, Kelly J.; Buonocore, Darren J.; Chang, Jason C.; Jungbluth, Achim A.; Szabolcs, Matthias J.; Morjaria, Sejal; Mount, Sharon L.; Rekhtman, Natasha; Selbs, Elena; Sheng, Zong‐Mei; Xiao, Yongli; Kleiner, David E.; Pittaluga, Stefania; Taubenberger, Jeffery K.; Rapkiewicz, Amy V.; Travis, William D.
title: Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies
date: 2020-07-02
journal: Histopathology
DOI: 10.1111/his.14201
sha: 8af886cbb577c75e2f484e4c9792148fbdc95399
doc_id: 715719
cord_uid: l211d603

INTRODUCTION: We describe postmortem pulmonary histopathologic findings of COVID‐19 pneumonia in patients with a spectrum of disease course, from rapid demise to prolonged hospitalization. METHODS: Histopathologic findings in postmortem lung tissue from eight patients who died from COVID‐19 pneumonia were reviewed. Immunohistochemistry (IHC) and next generation sequencing (NGS) were performed to detect virus. RESULTS: Diffuse alveolar damage (DAD) was seen in all cases with a spectrum of acute phase and/or organizing phase. IHC with monoclonal antibodies against SARS‐CoV‐2 viral nucleoprotein and spike protein detected virus in areas of acute but not organizing DAD, with intracellular viral antigen and RNA expression seen predominantly in patients with duration of illness less than 10 days. Major vascular findings included thrombi in medium and large caliber vessels, platelet microthrombi detected by CD61 IHC, and fibrin microthrombi. CONCLUSIONS: Presence of SARS‐CoV‐2 viral RNA by NGS early in the disease course and expression of viral antigen by IHC exclusively in the acute but not in the organizing phase of DAD, suggests that the virus may play a major role in initiating the acute lung injury of DAD, but when DAD progresses to the organizing phase, the virus may have been cleared from the lung by the patient’s immune response. These findings suggest the possibility of a major change during the disease course of COVID‐19 pneumonia that may have therapeutic implications. Frequent thrombi and microthrombi may also present potential targets for therapeutic intervention.

In March of 2020, New York became the epicenter of the worldwide Coronavirus Disease 2019 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus that emerged via animal to human transmission in Wuhan, China in late 2019 (1) . As of June 23, 2020, there have been 8,993,659 reported COVID-19 cases and 469,587 COVID-19-related deaths globally (2) .

Of these, 2,302,288 and 120,333 occurred in the United States, respectively, with New York State representing a large proportion, with 389,666 total cases and 24,782 deaths. (2) (3) (4) As of June 1, 2020, there have been 6,057,853 reported COVID-19 cases and 371,166 COVID-19related deaths globally (2) . Of these, 1,547,973 and 92,923 occurred in the United States, respectively, with New York State representing a large proportion, with 361,515 total cases and 23,391 deaths (3, 4) .

While most individuals exposed to SARS-CoV-2 remain asymptomatic or develop mild to moderate symptoms including cough, fatigue and fever or chills, approximately 20% develop severe shortness of breath and respiratory failure resulting in acute respiratory distress syndrome requiring assisted oxygenation (5) .

Mortality in critically ill patients is high, with reports of 21-28% in hospitalized patients and 61% in critically ill patients (6) (7) (8) . In New York specifically, mortality among COVID-19 patients requiring mechanical ventilation has been reported to reach up to 88% (9) .

Diffuse alveolar damage (DAD) has been the main finding in the emerging histopathologic studies of COVID-19 pneumonia, (10) (11) (12) (13) (14) (15) (16) (17) but there has been little attention focused on the progression of DAD from acute to organizing phase and its relationship to clearance of SARS-CoV-2 from the lungs.

Herein, we report comprehensive postmortem pulmonary histopathologic findings of COVID-19 pneumonia, across a spectrum of disease course, including IHC and viral RNA studies to address key questions regarding the pathogenesis of this disease.

This study was conducted following expedited institutional review board approval (Protocol #17-630) and comprised review of lung pathology specimens from eight patients who died from COVID-19 pneumonia.

Mean time interval from death to postmortem exam was 53 hours (range 

This article is protected by copyright. All rights reserved Patient demographics and clinical, laboratory and imaging data were extracted from medical records.

These data and complete full autopsy findings from patients 1-5, 7 and 8 have also been submitted to a clinical journal without emphasis on pulmonary histology (20) .

Published criteria were used for classifying DAD as acute or organizing phases (21, 22) . Details of histologic evaluation are summarized in the Supplemental Methods.

IHC was performed using two monoclonal antibodies to SARS-CoV comprising of clone 001, (1:5K, SinoBioogical, Wayne, PA) to viral nucleoprotein and clone 1A9, (1:1K; GeneTex, Irvine, CA) to the S2 spike protein. Both reagents were extensively analyzed for their reactivity and specificity (manuscript in preparation)(23) and utilized on 2-3 tissue sections from each COVID-19 case and 1-2 sections from each control non-COVID DAD case. Methods of IHC staining for lymphoid markers and CD61 are summarized in the Supplemental Methods.

RNA was extracted from the FFPE autopsy sections and next generation sequencing (NGS) was performed to detect virus as previously described (24) . More information about the methods are in the Supplementary Materials.

All eight patients (4 women, 4 men) were relatively young with a median age of 57.5 years (range 39-65). Most patients, 75% (6/8), were obese. Median body mass index of the cohort was 33.9 Kg/m 2 (range 23.0-53.2). Five (62.5%) patients were never smokers, two (25%) were former smokers and one (patient 2) was a current smoker.

All patients, except patient 7, had multiple comorbidities. Most had either pre-diabetes or type II diabetes mellitus (n = 5), hyperlipidemia (n = 4) and cardiovascular disease (either hypertension [n = 6] or

This article is protected by copyright. All rights reserved prior history of myocardial infarction [n = 1]). Patient 2 had chronic obstructive pulmonary disease, and patient 4 had obstructive sleep apnea managed with home continuous positive airway pressure. The remaining patients had no documented pulmonary disease.

All patients presented in respiratory distress, except patient 2 who became asystolic during ambulance transport and was pronounced dead shortly after arriving at the hospital. Duration of symptoms prior to hospital admission varied from a few days (patient 2) to up to two weeks (patients 7 and 8). All patients experienced shortness of breath and cough prior to admission. Fevers (100.7-102.5F) were reported for all patients except patients 2 and 8. Additional clinical features as well as laboratory findings are mentioned in the Supplemental materials.

Chest X-ray reports were available for 7 patients, but not patient 2 as she died upon arrival to the hospital. Bilateral pulmonary infiltrates/opacities, suggestive of multifocal pneumonia were seen in all 7 patients.

Duration of disease from onset of symptoms to death ranged from 3 (patient 1) to 25 (patient 7) days (Table 1 ). All patients, except patients 1 and 2, were managed with mechanical ventilation (median duration 2.5 days; range <1 to 11 days) ( Table 1) .

Internal examinations revealed that the lungs were heavy in all cases with combined postmortem lung weights ranging from 1630 (patient 3) to 2380 grams (patient 6).

This article is protected by copyright. All rights reserved

The major findings in this study include 1) DAD with presence of viral antigen and RNA in acute DAD with duration of illness less than 10 days in contrast to loss of viral antigen and RNA in cases with more organizing DAD with longer duration of illness, 2) vascular thrombi including microthrombi, 3) inflammatory cells differed between acute versus organizing DAD with neutrophils in the former and chronic inflammatory cells in the latter, 4) histologic findings of acute bronchopneumonia and 5) bronchitis and bronchiolitis (Table   1) .

Histologic sections of lung in all cases showed heterogeneous features with varying stages of acute and/or organizing DAD (Figure 1 ), sometimes adjacent to areas of relatively preserved alveolar parenchyma.

The acute/exudative phase of DAD was the primary finding in cases 1 and 2, characterized by hyaline membranes, alveolar and interstitial edema, with atypical type II pneumocyte proliferation, alveolar fibrin and frequent pneumocyte desquamation into alveolar spaces ( Figure 1A -D). The latter may be postmortem artifact rather than a true pathologic finding. Organizing DAD, with or without focal acute changes, was the primary finding in the remaining cases. No acute DAD was seen in case 6. Organizing DAD was characterized by alveolar wall thickening due to fibroblastic proliferation and prominent type II pneumocyte proliferation often with atypical reactive changes ( Figure 1E ). Pulmonary edema was observed in seven cases ( Figure 1B) , with interlobular septal thickening by edema seen in cases 1 and 4 ( Figure 1A ).

In areas showing acute phase of DAD, interstitial neutrophilic infiltrates were focally prominent ( Figure 1C ). In five of the six cases with organizing DAD, there was mild to moderate interstitial chronic inflammation composed of lymphocytes, plasma cells and histiocytes in alveolar walls and within areas of proliferating connective tissue ( Figure 1E ), most prominent in case 6 ( Figure 1F ).

Reactive type II pneumocytes displayed abundant eosinophilic cytoplasm with focal areas of cytoplasm showing a foamy appearance. Nuclei were enlarged, many with irregular nuclear contours, containing vesicular condensed chromatin and prominent macronucleoli ( Figure 1D 

IHC with a monoclonal antibody against SARS-CoV nucleoprotein detected virus in 6/8 (75%) study cases ( Table 2) and was negative in all non-COVID DAD control tissue, confirming previously established antibody specificity (manuscript in preparation). Similar results were obtained with monoclonal antibody against SARS-CoV spike protein, but staining was weaker. Most notably, staining for both antibodies was confined to areas of acute DAD but absent in areas with organizing phase of DAD, nicely highlighted in case 3 with both phases of DAD represented in a single section (Figure 2A-B) . This finding also accounts for lack of immunoreactivity in two cases (6 and 7), due to absence of acute DAD in the sections available for staining. Results of IHC for lymphoid markers and CD61 are summarized in Supplemental Results.

In cases 1-3 with time from disease onset to death of less than 10 days (1, 7 and 9 days, respectively) and predominantly acute DAD histologically, SARS-CoV-2 viral RNA was detected by NGS, (25, 26) which was not detected in cases 4-8 where duration of disease was greater than 10 days (13, 16, 20, 25 , and 17 days, respectively) and lung histology showed predominantly organizing DAD (Table 2) . Notably, these cases were either negative for viral antigen by IHC (6 and 7) or positive staining was seen predominantly in hyaline membranes within focal areas of acute DAD (4, 5 and 8). Case 3 was an exception in that viral RNA was detected at a low level by NGS despite staining by IHC being confined to hyaline membranes. Of note, in this

This article is protected by copyright. All rights reserved case, the block used for RNA extraction contained more abundant areas of acute DAD than the section used for IHC, which may explain this result.

This article is protected by copyright. All rights reserved

Our study provides novel observations documenting a major change that occurs in the pathogenesis of COVID-19 pneumonia as DAD progresses from the acute to the chronic phase. The presence of SARS-CoV antigen by IHC exclusively in areas of acute phase DAD but not in areas of organizing phase of DAD and detection of viral RNA by NGS early in the course of disease (<10 days) suggest that the virus plays a major role in initiating acute lung injury of DAD. However, after the first 10 days of illness and/or when DAD progresses to the organizing phase, the viral RNA and protein may have been cleared by the patient's immune response. While this manuscript was in review, another study was published validating our findings that SARS-CoV-2 is mainly present in early stages of DAD and was absent in areas of organizing phase of DAD. (27) In contrast to our report, this study used a single polyclonal rather than two monoclonal antibodies for immunohistochemistry and did not report any staining of control non-COVID DAD cases or provide viral RNA testing of lung tissues. (27) Our finding that both monoclonal antibodies showed IHC expression of viral antigen in type II pneumocytes and alveolar macrophages as well as hyaline membranes corresponds well to the localization of coronavirus virions previously identified by electron microscopy (28) . The nucleoprotein antibody (001) showed more extensive staining than the spike protein antibody (1A9) raising consideration of differences in sensitivity and specificity among antibodies. We noted peculiar staining of hyaline membranes with both SARS-CoV antibodies in all IHC-positive cases. Although non-specific staining would be a consideration, the absence of staining in hyaline membranes of control non-COVID DAD cases confirms its specificity. Another report of identification of virions in hyaline membranes supports our finding (28) . This observation of the presence of viral protein antigens in hyaline membranes in the absence of detectable viral RNA is not unique to SARS-CoV-2 infections and has also been observed in influenza A autopsy studies from the 1918 and 2009 pandemics (24, 29) . Viral proteins still detectable in hyaline membrane material probably reflect remnants of lytic infections. RNA is much less stable than proteins given ubiquitous RNAases and this is the likely explanation for our observations and those in prior influenza autopsy studies (30) .

Notably, in our cohort, the most prominent intracellular viral antigen was detected in the two cases (Cases 1 and 2) with the most acute presentation and rapid disease course (7 and 3 days, respectively) and with only acute DAD histology, and corresponds to the cases with highest levels of SARS-CoV2 RNA detected by NGS in this cohort. This pattern of expression in both pneumocytes and hyaline membranes during the initial injury, and apparent progressive loss of expression from pneumocytes later in disease course may Accepted Article represent the process of viral clearance, whereby viral proteins are released into alveolar spaces from infected pneumocytes damaged by direct lytic action and/or by inflammatory cell/immune mediated injury, and are cleared by the patient's immune system later in the disease course, histologically manifesting as organizing phase of DAD as the lung attempts to repair. Also, it is important to note that the histologic findings are heterogeneous in these cases, with varying amounts of acute and organizing DAD in different areas of the same lungs. Therefore, it is possible that clearance of the virus may be a local rather than global effect, until the DAD progresses to exclusively organizing phase.

As published data rapidly accumulates regarding SARS-CoV IHC in lung tissues from patients with COVID-19 pneumonia, careful attention to methodology must be observed, including particular antibodies (polyclonal vs monoclonal) and antigen detected (spike vs nucleoprotein), pattern of lung injury evaluated (acute vs organizing DAD or bronchopneumonia), localization of immunoreactivity (pneumocytes, hyaline membranes, macrophages, endothelial cells or bronchial epithelial cells), and duration of illness. Variation in each of these factors may impact differences in reported results (27, 28, (31) (32) (33) . It should also be noted that some antibodies being utilized in published reports, including the ones we utilized, are not specific to SARS-CoV-2, because they also react with SARS-CoV-1. However, in the current pandemic, the differential diagnosis between these two SARS-CoV infections is not a major question. In addition, although we confirmed the presence of viral antigen in lung tissue from our COVID-19 patients, we did not identify any definite viral inclusions (Supplemental Results and Discussion).

Interestingly, lung histology from two patients who died rapidly with little or no mechanical ventilation showed acute DAD, while lung histology from the other six patients who received mechanical ventilation showed predominantly organizing DAD, in addition to acute changes in five patients. Additionally, the type of inflammation in the lung changed with the phase of DAD from neutrophils in the acute phase to chronic inflammatory interstitial infiltrates in organizing DAD. This finding raises the consideration that lymphocytes, plasma cells and histiocytes may also have a pathogenic role, perhaps in the immune response to and clearance of the virus. We cannot exclude the possibility that the presence of these chronic inflammatory cells could be related to the longer periods of mechanical ventilation in these patients.

However, in DAD due to other etiologies, neutrophils have been described early in the course of disease and other chronic inflammatory cells in later stages regardless of whether mechanical ventilation has been used or not (34-40). In other viral pneumonias, including influenza (41) (42) (43) (44) and Ebola (45) , the host inflammatory response has been shown to play a distinct role in pathogenesis in addition to direct damage from viral

This article is protected by copyright. All rights reserved infections. It is reasonable to hypothesize that this is also the case in severe SARS-CoV-2 infections, but more research on this question is needed.

Emerging literature regarding COVID-19 pneumonia supports our findings that viral clearance from the lung may occur as DAD progresses to the organizing phase. Clinical evidence has shown that SARS-CoV-2 viral load, transmissibility and pharyngeal virus shedding peaks within the first week of disease (46) (47) (48) (49) . This is an interesting observation and should be further studied in other viral pneumonias to determine if it is unique to COVID-19 pneumonia. These findings may have important therapeutic implications, such that antiviral agents may be useful in early stages of COVID-19 pneumonia, but after 10-14 days, when virus has been cleared from the lungs, it may be best to transition the focus of therapy to managing organizing DAD.

However, determining the clinical utility of our findings for guiding therapy requires validation in larger cohorts. Viral antigen was detected by IHC very focally in endothelial cells in one case in this cohort. However, this is insufficient evidence to suggest primary infection of endothelial cells plays a major role in vascular

This article is protected by copyright. All rights reserved injury or DAD in COVID-19 pneumonia. The suggestion based upon ultrastructural findings, that SARs-CoV-2 directly infects endothelial cells (53, 54) has been disputed. Goldsmith et al pointed out that images published as putative virions within endothelial cells actually represented normal cellular structures such as endoplasmic reticulum rather than virus (55) . Like our study, Shieh et al described positive IHC for H1N1 influenza in endothelium only in rare cases (51). Furthermore, although we did observe thrombi, microthrombi and focal vascular inflammation (Supplemental Results, Discussion and Supplemental Figure 2) we did not observe lesions of thrombotic necrotizing capillary injury, endothelial cell necrosis or endothelialitis as reported by others (32, 53) . Nevertheless, further study of the role of SARS-CoV-2 in endothelial cell injury is warranted to better understand the pathogenesis of viral infection in this disease.

In summary, our findings suggest that the initial lung injury in fatal COVID-19 pneumonia is directly caused by SARS-CoV-2 in the acute phase of DAD. As DAD progresses to the organizing phase, viral RNA and antigen become undetectable, suggesting possible clearance by the patient's immune response. These findings suggest the pathogenesis of COVID-19 pneumonia undergoes a major change during disease course and raises consideration for different therapeutic approaches, depending on whether DAD has progressed to the organizing phase. within areas of acute phase DAD, and in two cases diffusely within regenerating and reactive type II pneumocytes (arrowheads). Viral antigen was also present in alveolar macrophages in these latter two cases (D). In Case 1, the case with the most viral antigen detected by IHC, weak cytoplasmic staining was observed in endothelial cells of scattered venules and alveolar capillaries (E).

This article is protected by copyright. All rights reserved 

This article is protected by copyright. All rights reserved The neutrophils were seen focally in areas of acute DAD and the lymphocytes in areas of organizing DAD.

c Vascular changes seen on histologic examination of H&E-stained slides without assistance of immunohistochemistry include thrombi, fibrin microthrombi and vasculitis. Platelet microthrombi by CD61 immunohistochemistry were seen in all cases.

*Clinical and limited pulmonary pathology data for patients 1-5, 7 and 8 will be published in EClinicalMedicine (20) .

This article is protected by copyright. All rights reserved Clean Copy: Table   2 . 

Pneumonia of unknown cause -China. [Internet]: World Health Organization (WHO)

Coronavirus disease (COVID-19): Situation Report -155. [Internet]: World Health Organization (WHO)

COVID-19): Cases, Data & Surveillance

Workbook: NYS-COVID-19-Tracker

Tracker/NYSDOHCOVID-19Tracker-Fatalities?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n

Clinical characteristics of 3,062 COVID-19 patients: a metaanalysis

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The lancet Respiratory medicine

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Targeting potential drivers of COVID-19: Neutrophil extracellular traps. The Journal of experimental medicine

COVID-19 Autopsies

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective

Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Modern pathology : an official journal of the United States and Canadian Academy of Pathology

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19

Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The lancet Respiratory medicine

Autopsy Report with Clinical Pathological Correlation

Vander Heide RS. Pulmonary and cardiac pathology in Covid-19: The first autopsy series from New Orleans. Cardiovascular Path. 2020;In press

cobas® SARS-CoV-2 Test (for the COVID-19 Coronavirus)

Megakaryocytes and plateletfibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19

Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. The American journal of pathology

Diffuse Alveolar Damage and Acute Interstitial Pneumonia

Accepted Article This article is protected by copyright. All rights reserved 23

Immunohistochemical Reagents for In-Situ Protein Expression Analysis of Coronavirus-Associated Changes in Human Tissues

Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak

Deep sequencing of

A/H1N1 virus isolated from volunteer human challenge study participants and natural infections

Deep Sequencing of H7N9 Influenza A Viruses from

Infected Patients from 2013 to 2015 in Shanghai Reveals Genetic Diversity and Antigenic Drift. mSphere

In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19. Modern pathology : an official journal of the United States and Canadian Academy of Pathology

Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States. Emerging infectious diseases

Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections

Immune Modulation by Human Secreted RNases at the Extracellular Space

Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Translational research : the journal of laboratory and clinical medicine

Immunostaining in the Lung of a Patient With COVID-19

Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review

Neutrophil activation and acute lung injury. Current opinion in critical care

Mechanisms and mediators of the adult respiratory distress syndrome

Initiation of LPS-induced pulmonary dysfunction and its recovery occur independent of T cells

Pulmonary pathology of acute respiratory distress syndrome

Lethal synergism of

Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice. Free radical biology & medicine

The pathology of influenza virus infections

The 1918 influenza pandemic: 100 years of questions answered and unanswered. Science translational medicine

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease

Predicting infectious SARS-CoV-2 from diagnostic samples. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Accepted Article This article is protected by copyright. All rights reserved 47

Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset

Chronological Changes of Viral Shedding in

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Virological assessment of hospitalized patients with COVID-2019

Post-mortem examination of COVID19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction

Evolution of severe acute respiratory syndrome coronavirus 2 RNA test results in a patient with fatal coronavirus disease 2019: a case report

Endothelial cell infection and endotheliitis in COVID-19

Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China